Acquired von Willebrand Syndrome (AVWS) is a rare bleeding disorder characterized by quantitative or qualitative defects of von Willebrand factor (VWF) in patients without a personal or family history... HTML Version |
PDF Version
|
Print the excerpt
Von Willebrand disease (VWD) is the most common inheritedbleeding disorder, but its true burden remains difficult to quan-tify because many affected individuals are never diagnosed orare diagnosed only... HTML Version |
PDF Version
|
Print the excerpt
Von Willebrand factor (VWF) concentrate prophylaxis is recommended for patients with severe von Willebrand disease (VWD) or VWD with frequent bleeding symptoms but remains underutilized, in part due to... HTML Version |
PDF Version
|
Print the excerpt
Tissue factor pathway inhibitor (TFPI), a key regulator of tissue factor-initiated coagulation through FXa-dependent inhibition of the tissue factor-FVIIa complex, has emerged as a promising target for... HTML Version |
PDF Version
|
Print the excerpt
By requesting access to the "WillebrandXPERT" service, I agree that GNM Healthcare Group Companies USA, Inc. may use the data acquired during my access request to provide me with weekly
information related to its services in accordance with the
Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to
dpo@gnmhealthcare.com.
You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.
